insulin requiring type 1 or type 2 diabetes
Item
subjects with insulin requiring type 1 or type 2 diabetes for at least 24 months
boolean
C0011849 (UMLS CUI [1])
insulin
Item
current treatment with human insulin (either premix of short and long/intermediate acting insulin) in a twice daily treatment regimen preparation and/or self-mix for at least 12 months
boolean
C0021641 (UMLS CUI [1])
body mass index
Item
body mass index (bmi) below or equal to 35.0 kg/m^2
boolean
C1305855 (UMLS CUI [1])
hba1c
Item
hba1c below or equal to 11.0%
boolean
C0019018 (UMLS CUI [1])
total daily insulin dose at least 1.4 iu/kg
Item
total daily insulin dose at least 1.4 iu/kg
boolean
C0021641 (UMLS CUI [1])
oral hypoglycaemic agents
Item
treatment with oral hypoglycaemic agents within the month prior to inclusion
boolean
C0359086 (UMLS CUI [1])
hypoglycemia
Item
recurrent severe hypoglycaemia (as judged by the investigator)
boolean
C0020615 (UMLS CUI [1])
proliferative retinopathy
Item
active proliferative retinopathy
boolean
C0339467 (UMLS CUI [1])
impaired renal function with creatinine at least 150 mcmol/l (1.7 mg/dl)
Item
impaired renal function with creatinine at least 150 mcmol/l (1.7 mg/dl)
boolean
C0201976 (UMLS CUI [1])
pancreatitis
Item
history of pancreatitis
boolean
C0030305 (UMLS CUI [1])